| Active ingredients | | Date of last message | Type of reason | AM designation |
| BCG bacteria, strain TICE, live, attenuated | Change notification | 02.01.2026 | Other | OncoTICE |
| Salbutamol sulfate | Change notification | 02.01.2026 | Other | SalbuHEXAL N Metered dose inhaler |
| Salbutamol sulfate | Change notification | 02.01.2026 | Other | Salbutamol – 1 A Pharma 0.1 mg pressurized gas inhalation, suspension |
| Epoetin theta | Initial report | 02.01.2026 | Other | Eporatio 10,000 IU/1 ml injection solution in pre-filled syringe – OP (6x1ml) |
| Epoetin theta | Initial report | 02.01.2026 | Other | Eporatio 4000 IU/0.5 ml injection solution in pre-filled syringe – OP (6×0.5 ml) |
| Digoxin | Initial report | 30.12.2025 | Production problem | Lanicor |
| Teicoplanin | Change notification | 29.12.2025 | Other | Teicoplanin Eberth 200 mg powder for solution for injection/infusion or oral solution |
| Teicoplanin | Change notification | 29.12.2025 | Other | Teicoplanin Eberth 400 mg powder for solution for injection/infusion or oral solution |
| Etanercept | Initial report | 29.12.2025 | Other | Nepexto 50 mg solution for injection in a pre-filled syringe |
| Insulin glargine | Change notification | 29.12.2025 | Other | Semglee 100 units/ml solution for injection in a pre-filled pen – OP(5x3ml) |
| Insulin glargine | Change notification | 29.12.2025 | Other | Semglee |
| Lanreotide acetate (1:x) ((with information on acetic acid content)) | Change notification | 29.12.2025 | Production problem | Mytolac 60 mg solution for injection in a pre-filled syringe |
| Fosfomycin sodium (Ph.Eur.) | Change notification | 23.12.2025 | Production problem | Fosfomycin Eberth 2 g powder for solution for infusion |
| Fosfomycin sodium (Ph.Eur.) | Change notification | 23.12.2025 | Production problem | Fosfomycin Eberth 4 g powder for solution for infusion |
| Galantamine hydrobromide | Change notification | 23.12.2025 | Production problem | Galantamine Heumann 24 mg hard capsules, delayed release |
| Galantamine hydrobromide | Change notification | 23.12.2025 | Production problem | Galantamine Heumann 16 mg hard capsules, delayed release |
| Galantamine hydrobromide | Change notification | 23.12.2025 | Production problem | Galantamine Heumann 8 mg hard capsules, delayed release |
| Quetiapine fumarate (Ph.Eur.) | Change notification | 23.12.2025 | Production problem | Quetiapine Heumann retard 300 mg prolonged-release tablets |
| Quetiapine fumarate (Ph.Eur.) | Change notification | 23.12.2025 | Production problem | Quetiapine Heumann retard 400 mg prolonged-release tablets |
| Quetiapine fumarate (Ph.Eur.) | Change notification | 23.12.2025 | Production problem | Quetiapine Heumann retard 50 mg prolonged-release tablets |
| Quetiapine fumarate (Ph.Eur.) | Change notification | 23.12.2025 | Production problem | Quetiapine Heumann retard 150 mg prolonged-release tablets |
| Quetiapine fumarate (Ph.Eur.) | Change notification | 23.12.2025 | Production problem | Quetiapine Heumann retard 200 mg prolonged-release tablets |
| Oxycodone hydrochloride (Ph.Eur.) | Initial report | 22.12.2025 | Production problem | Oxygesic injection 10 mg/ml |
| Morphine hemisulfate 2.5 hydrate | Initial report | 22.12.2025 | Production problem | MSI 10 mg Mundipharma |
| Oxycodone hydrochloride | Initial report | 22.12.2025 | Production problem | Oxygesic 80 mg |
| Adalimumab | Change notification | 22.12.2025 | Other | Amsparity |
| Adalimumab | Change notification | 22.12.2025 | Other | Amsparity |
| Fluconazole | Change notification | 22.12.2025 | Other | Flucoderm capsules 50 mg |
| Lidocaine hydrochloride monohydrate | Change notification | 22.12.2025 | Other | Xylocaine Gel 2% |
| Hydrocortisone | Initial report | 22.12.2025 | Other | Hydrocutan cream 1% |
| Fusidic acid (Ph.Eur.) | Change notification | 22.12.2025 | Other | Fusicutan ointment |
| Imiquimod | Change notification | 22.12.2025 | Production problem | Imikeraderm 50 mg/g cream |
| Cefaclor monohydrate | Change notification | 22.12.2025 | Other | Cefaclor 125 TS – 1 A Pharma |